Litigation Details for Hilti Aktiengesellschaft v. Specified Technologies Inc. (D. Del. 2022)
✉ Email this page to a colleague
Hilti Aktiengesellschaft v. Specified Technologies Inc. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-10-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Christopher J. Burke |
| Jury Demand | Plaintiff | Referred To | |
| Parties | HILTI AKTIENGESELLSCHAFT | ||
| Patents | 10,202,759 | ||
| Attorneys | Chetan Chandra | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Hilti Aktiengesellschaft v. Specified Technologies Inc.
The biologic drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Hilti Aktiengesellschaft v. Specified Technologies Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-05-10 | 102 | Order - Memorandum and Order | 1 of asserted United States Patent No. 10,202,759 (the “'759 patent”). The preamble of claim 1 of…the other asserted patent, United States Patent No. 11,339,566 (the “'566 patent”) is not materially…in the patents’ titles. ('759 patent at 1; '566 patent at 1) And it is also …than the '759 patent. ('759 patent at 1; '566 patent at 1) When one looks…x27;759 patent at 1; id., cols. 3:18, 3:32-33, 3:65-66, 4:53-54; '566 patent at 1; | External link to document |
| 2022-10-27 | 7 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,202,759 B2 Added. (Kraman… 21 October 2022 1:22-cv-01383 Patent Plaintiff District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
